Quantcast

Latest Insulin glargine Stories

2011-06-07 07:00:00

BRIDGEWATER, N.J., June 7, 2011 /PRNewswire/ -- Actors Paul and Mira Sorvino today announce the Diabetes Co-Stars: Cook-Off. This nationwide recipe contest runs from June 7-July 20, 2011 and is a continuation of their work with sanofi-aventis U.S.

2011-02-09 06:30:00

PARIS, Feb.

2010-12-07 22:19:38

A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.

2010-09-30 05:58:00

COPENHAGEN, September 30, 2010 /PRNewswire/ -- Zealand Pharma A/S, the biopharmaceutical company dedicated to the discovery and development of innovative peptide-based drugs, is pleased to note that its partner, sanofi-aventis, has today announced positive top-line results of the Phase III GETGOAL-L-ASIA trial which assessed the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist discovered by Zealand Pharma, in combination with basal insulin.

2010-09-20 07:30:00

PARIS, Sept. 20 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today results of two studies presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.

2010-06-26 09:05:00

PARIS, June 26 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today results of a study which demonstrated that patients using Lantus® (insulin glargine [rDNA origin] injection) once-daily and Apidra® (insulin glulisine [rDNA origin] injection) before meals reported improved patient reported outcomes and decreased glycemic variability versus premix analog insulin.

2010-06-25 15:20:00

PARIS, June 25 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus® (insulin glargine [rDNA origin] injection) once-daily and Apidra® (insulin glulisine [rDNA origin] injection) before meals improved glycemic...

2010-04-29 07:00:00

PARIS, April 29 /PRNewswire-FirstCall/ -- Change on Change at a constant reported exchange Q1 2010 Q1 2009 basis rates ------- ------- --------- --------- EUR EUR Net sales 7,385m 7,107m +3.9%...

2010-04-01 07:30:00

JERSEY CITY, N.J., April 1 /PRNewswire/ -- Diabetes is a national epidemic. In the United States, a person is diagnosed with diabetes every 21 seconds.

2010-03-31 00:00:00

SALEM, N.H., March 31 /PRNewswire/ -- AgaMatrix, Inc. and sanofi-aventis (EURONEXT: SAN and NYSE: SNY) today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions.


Word of the Day
alicorn
  • The horn of a unicorn considered as a medical or pharmacological ingredient.
  • A winged horse with a single horn on its head; a winged unicorn.
The word 'alicorn' comes from Italian alicorno, already associated with unicorns and reinterpreted, popularized by Bearing an Hourglass (1984) and other fantasy novels by Piers Anthony.
Related